Methods and compositions for noninvasive dose-to-effect...

Details Methods and compositions for noninvasive dose-to-effect... Methods and compositions for noninvasive dose-to-effect...

A - Human Necessities

61

K

167/159, 167/165

A61K 9/00 (2006.01) A23G 3/00 (2006.01)

Patent

CA 1339075

The present invention is directed to methods and compositions for noninvasively administering lipophilic drugs in a dose-to-effect manner to produce antimigraine, oxytocic, antiemetic, hypoglycemic, anti-Parkinsonian, antidiuretic, antifungal, antisecretory, or bronchodilator activity. A patient is put at ease when given the lollipop, and the lipophilic drug rapidly enters the patient's bloodstream as the lollipop is sucked. When treating the patient, the physician can observe the patient's condition and terminate the use of the lollipop when it has had a desired effect on the patient. The drug-containing lollipop can be self-administered by the patient in response to subjective symptoms and to the patient's susceptibility to the lipophilic drug.

610329

Affiliated with

Also associated with

Rating

Methods and compositions for noninvasive dose-to-effect... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for noninvasive dose-to-effect..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for noninvasive dose-to-effect... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1244787